Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
Roche cancer treatment priced at $17,050 a month, lower than rival Vitrakvi
FILE PHOTO: The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland February 1, 2018. REUTERS/Arnd…
Drug makers met with Trump to argue against Senate pricing bill
(Reuters) – The main pharmaceutical industry lobbying group said on Thursday it and some drugmakers met with President Donald Trump…
Drug shortages may add $230 million to annual U.S. drug costs
(Reuters Health) – Prescription drug shortages may drive up prices twice as much as they would rise with medicines in…